{"created":"2024-03-28T00:46:14.642390+00:00","id":2000159,"links":{},"metadata":{"_buckets":{"deposit":"ffe29cb0-a422-44f8-a7c4-66ffef2a637a"},"_deposit":{"created_by":15,"id":"2000159","owner":"15","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"2000159"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:02000159","sets":["611:939:940"]},"author_link":[],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2023","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"4","bibliographicPageEnd":"4258","bibliographicPageStart":"4250","bibliographicVolumeNumber":"12","bibliographic_titles":[{"bibliographic_title":"Cancer Medicine","bibliographic_titleLang":"en"}]}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"John Wiley & Sons","subitem_publisher_language":"en"}]},"item_10001_relation_25":{"attribute_name":"関連情報","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1002/cam4.5292","subitem_relation_type_select":"DOI"}}]},"item_10001_version_type_20":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1724099666130":{"attribute_name":"収録物識別子","attribute_value_mlt":[{"subitem_source_identifier":"2045-7634","subitem_source_identifier_type":"EISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"作成者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Takahashi, Naoto","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kameoka, Yoshihiro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Onizuka, Makoto","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Onishi, Yasushi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takahashi, Fumiaki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Dan, Takashi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Miyata, Toshio","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ando, Kiyoshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Harigae, Hideo","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-03-28"}],"filename":"iA_2023_29.pdf","filesize":[{"value":"386 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"url":"https://air.repo.nii.ac.jp/record/2000159/files/iA_2023_29.pdf"},"version_id":"6df2cd94-1fa4-4816-b1fc-2fdba5a985e6"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"BCR-ABL1","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"chronic myeloid leukemia","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"PAI-1 inhibitor","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"tyrosine kinase inhibitor","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor‐1 inhibitor TM5614 combined with a tyrosine kinase inhibitor","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor‐1 inhibitor TM5614 combined with a tyrosine kinase inhibitor","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"15","path":["940"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-03-28"},"publish_date":"2024-03-28","publish_status":"0","recid":"2000159","relation_version_is_last":true,"title":["Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor‐1 inhibitor TM5614 combined with a tyrosine kinase inhibitor"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2024-08-22T17:19:44.374586+00:00"}